JP2022532801A5 - - Google Patents

Info

Publication number
JP2022532801A5
JP2022532801A5 JP2021569297A JP2021569297A JP2022532801A5 JP 2022532801 A5 JP2022532801 A5 JP 2022532801A5 JP 2021569297 A JP2021569297 A JP 2021569297A JP 2021569297 A JP2021569297 A JP 2021569297A JP 2022532801 A5 JP2022532801 A5 JP 2022532801A5
Authority
JP
Japan
Prior art keywords
substituted
alkoxy
alkyl
alkylamino
dialkylamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021569297A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022532801A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/034415 external-priority patent/WO2020237225A1/en
Publication of JP2022532801A publication Critical patent/JP2022532801A/ja
Publication of JP2022532801A5 publication Critical patent/JP2022532801A5/ja
Pending legal-status Critical Current

Links

JP2021569297A 2019-05-22 2020-05-22 がんの治療において使用するための官能基化金カルベンナフトキノン錯体 Pending JP2022532801A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962851187P 2019-05-22 2019-05-22
US62/851,187 2019-05-22
PCT/US2020/034415 WO2020237225A1 (en) 2019-05-22 2020-05-22 Functionalized gold carbene naphthoquinone complexes for use in the treatment of cancer

Publications (2)

Publication Number Publication Date
JP2022532801A JP2022532801A (ja) 2022-07-19
JP2022532801A5 true JP2022532801A5 (https=) 2023-06-01

Family

ID=73459479

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021569297A Pending JP2022532801A (ja) 2019-05-22 2020-05-22 がんの治療において使用するための官能基化金カルベンナフトキノン錯体

Country Status (11)

Country Link
US (1) US12577262B2 (https=)
EP (1) EP3972981A4 (https=)
JP (1) JP2022532801A (https=)
KR (1) KR20220024123A (https=)
CN (1) CN114174305A (https=)
AU (1) AU2020279478A1 (https=)
CA (1) CA3140716A1 (https=)
IL (1) IL288176A (https=)
MX (1) MX2021014195A (https=)
SG (1) SG11202112856QA (https=)
WO (1) WO2020237225A1 (https=)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201003483D0 (en) * 2010-03-02 2010-04-14 Univ St Andrews Gold complexes
US8900654B2 (en) * 2011-07-29 2014-12-02 Thin Film Electronics, Inc. Methods of polymerizing silanes and cyclosilanes using N-heterocyclic carbenes, metal complexes having N-heterocyclic carbene ligands, and lanthanide compounds
HUE033704T2 (en) 2012-02-13 2017-12-28 Bristol Myers Squibb Co Enediyne compounds, conjugates thereof, and uses and methods therefor
US20170129911A1 (en) 2015-11-10 2017-05-11 Massachusetts Institute Of Technology Complexes comprising a platinum compound and an immune checkpoint inhibitor and related methods
WO2019006327A1 (en) * 2017-06-30 2019-01-03 Board Of Regents, The University Of Texas System OR-CARBENE COMPLEXES CONTAINING NAPHTOQUINONE AND METHODS OF USE

Similar Documents

Publication Publication Date Title
TWI868726B (zh) 抗體-藥物結合物之新穎製造方法
JP6854759B2 (ja) 腫瘍微環境によって特異的活性化する小分子標的結合体およびその使用
WO2022078259A1 (zh) 一种氘代的喜树碱衍生物及其抗体药物偶联物
CN115160403B (zh) 特异性拓扑异构酶抑制剂和可用于抗体药物偶联物及其制备方法
BR112019008335A2 (pt) conjugado de um anticorpo, composição farmacêutica e método para o tratamento e/ou a prevenção de um câncer
TW202317199A (zh) 配體藥物偶聯物及其應用
CN111001012A (zh) 一种亲水碳酸酯型抗体偶联药物
JP2021524439A5 (https=)
CN113995846A (zh) 聚乙二醇偶联药物增效剂、其制备方法及用途
WO2022126593A1 (zh) 一种靶向trop2的抗体药物偶联物、其制备方法及应用
CN113248475B (zh) 一类杂环取代的苯并咪唑二聚体或其药学上可接受的盐、组合物及其用途
WO2024230763A1 (zh) 一种新型的靶向化合物和核酸缀合物,及其用途
CN101454309B (zh) 焦谷氨酸衍生物的合成和用途
JP2022532801A5 (https=)
AU2008286742B2 (en) Protein-polymer conjugates
ES2255269T3 (es) Subunidad b de la verotoxina para inmunizacion.
WO2025130549A1 (zh) 一种靶向整合素αvβ6的配体、缀合物、组合物以及它们的用途
US20250213645A1 (en) Pharmaceutical composition for modulating immune response
ES2910659T3 (es) Nuevo derivado de PEG
JP2018525346A5 (https=)
CN121378257B (zh) 靶向叶酸受体的化合物、组合物、其制备方法及应用
JP2025500942A5 (https=)
US20250325676A1 (en) Camptothecin prodrug and pharmaceutical composition thereof
WO2025092703A1 (zh) 光敏剂偶联体化合物及其药物组合物和应用
WO2025261479A1 (zh) 以丁二酰基为连接链的偶联物及其制备方法和用途